- ISIN
- US5165441032
- CUSIP
- 516544103
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Jun 25, 2015
Highlights
- Market Cap
- $6.98B
- Enterprise Value
- $6.49B
- EPS (TTM)
- $4.13
- PE Ratio
- 25.70
- PEG Ratio
- 0.10
- Total Revenue (TTM)
- $1.55B
- Gross Profit (TTM)
- $935.17M
- EBITDA (TTM)
- $369.99M
- Year Range
- $47.25 - $107.99
- Target Price
- $99.25
- ROA (TTM)
- 11.89%
- ROE (TTM)
- 23.02%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LNTH Performance Chart
Lantheus Holdings, Inc. (LNTH) is up 59.6% since the beginning of the year. At $106 per share, LNTH is trading just below its 52-week high of $108. Investors who bought $1,000 worth of LNTH shares 5 years ago would now be looking at an investment worth $4,089.
Loading charts...
Returns By Period
Lantheus Holdings, Inc. (LNTH) has returned 59.58% so far this year and 34.11% over the past 12 months. Looking at the last ten years, LNTH has achieved an annualized return of 44.05%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.
Lantheus Holdings, Inc.
- 1D
- 2.25%
- 1M
- 3.11%
- YTD
- 59.58%
- 6M
- 56.15%
- 1Y
- 34.11%
- 3Y*
- 4.70%
- 5Y*
- 32.53%
- 10Y*
- 44.05%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
LNTH Monthly Returns History
Based on dividend-adjusted daily data since Jun 25, 2015, LNTH's average daily return is +0.18%, while the average monthly return is +3.86%. At this rate, an investment would double in approximately 1.5 years.
Historically, 60% of months were positive and 40% were negative. The best month was Aug 2016 with a return of +124.0%, while the worst month was Jan 2016 at -35.8%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 4 months.
On a daily basis, LNTH closed higher 51% of trading days. The best single day was Aug 5, 2016 with a return of +54.2%, while the worst single day was Aug 6, 2025 at -28.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.56% | 11.94% | 1.25% | 11.56% | 17.35% | 6.95% | 59.58% | ||||||
| 2025 | 3.41% | 1.42% | 4.03% | 6.91% | -27.58% | 8.34% | -13.03% | -22.88% | -6.58% | 12.48% | 2.05% | 13.05% | -25.61% |
| 2024 | -16.24% | 25.90% | -4.80% | 6.91% | 22.98% | -1.88% | 30.56% | 1.56% | 3.08% | 0.08% | -18.73% | 0.21% | 44.29% |
| 2023 | 12.83% | 28.63% | 11.63% | 3.50% | 1.33% | -3.08% | 3.06% | -20.87% | 1.52% | -7.02% | 10.87% | -13.43% | 21.66% |
| 2022 | -12.05% | 88.19% | 15.66% | 20.07% | 3.18% | -3.63% | 16.19% | 2.71% | -10.75% | 5.20% | -16.10% | -17.91% | 76.39% |
| 2021 | 20.61% | 14.81% | 14.40% | 10.90% | 2.32% | 13.98% | -5.32% | 0.76% | -2.62% | -8.92% | 14.49% | 7.88% | 114.16% |
Benchmark Metrics
Lantheus Holdings, Inc. has an annualized alpha of 37.03%, beta of 1.13, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since June 25, 2015.
- This stock captured 119.20% of S&P 500 Index gains but only 38.90% of its losses - a favorable profile for investors.
- R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 37.03%
- Beta
- 1.13
- R²
- 0.10
- Upside Capture
- 119.20%
- Downside Capture
- 38.90%
Return for Risk
Risk / Return Rank
LNTH ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Lantheus Holdings, Inc. (LNTH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LNTH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.30 | ||
| Sortino ratioReturn per unit of downside risk | -1.62 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.37 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.85 | 2.78 | -1.93 |
| Martin ratioReturn relative to average drawdown | 1.50 | 12.44 | -10.94 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Lantheus Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Lantheus Holdings, Inc. was 78.62%, occurring on Feb 8, 2016. Recovery took 141 trading sessions.
The current Lantheus Holdings, Inc. drawdown is 14.09%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2016 bear market2016 | -78.62%Feb 2016 | 5mo 24d | 6mo 23d | 1y 12dAug 2015 - Aug 2016 |
COVID crash2020 | -68.52%Mar 2020 | 7mo 27d | 1y 7mo | 2y 3moJul 2019 - Nov 2021 |
2025 bear market2025 | -59.46%Sep 2025 | 1y 2mo | — | 1y 11moJul 2024 - now |
2024 bear market2024 | -48.75%Jan 2024 | 8mo 14d | 5mo 18d | 1y 1moMay 2023 - Jul 2024 |
Rate-hike selloffLate 2018 | -47.82%Oct 2018 | 9mo 6d | 4mo 20d | 1y 1moJan 2018 - Mar 2019 |
Drawdown Indicators
| LNTH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.62% | -56.78% | -21.84% |
Max Drawdown (1Y)Largest decline over 1 year | -40.22% | -9.10% | -31.12% |
Max Drawdown (3Y)Largest decline over 3 years | -59.46% | -18.90% | -40.56% |
Max Drawdown (5Y)Largest decline over 5 years | -59.46% | -25.43% | -34.03% |
Max Drawdown (10Y)Largest decline over 10 years | -68.52% | -33.92% | -34.60% |
Current DrawdownCurrent decline from peak | -14.09% | -1.80% | -12.29% |
Average DrawdownAverage peak-to-trough decline | -28.17% | -10.71% | -17.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.77% | 2.03% | +20.74% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Lantheus Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Lantheus Holdings, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for LNTH, comparing it with other companies in the Diagnostics & Research industry. Currently, LNTH has a P/E ratio of 25.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for LNTH compared to other companies in the Diagnostics & Research industry. LNTH currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for LNTH relative to other companies in the Diagnostics & Research industry. Currently, LNTH has a P/S ratio of 4.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for LNTH in comparison with other companies in the Diagnostics & Research industry. Currently, LNTH has a P/B value of 5.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LNTH
Add Lantheus Holdings, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LNTH